10:44 AM EST - Canopy Growth Corporation : And its wholly-owned subsidiary, Canopy Health Innovations Inc., announced that approval has been received from the Veterinary Drug Directorate of Health Canada to research the effectiveness of cannabidiol to treat anxiety in certain animals. The research will be conducted by Canopy Animal Health, a division of Canopy Health which focuses on developing cannabis-based healthcare products for companion animals. Canopy Growth Corporation
shares T.WEED are trading up $1.33 at $35.59.
